RLMD RELMADA THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · after market close
What 9 analyst firms say about RELMADA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 1 report on RLMD from 1 analyst firm in the last 90 days (9 firms in the past year).
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| H.C. Wainwright | Andres Y. Maldonado | Buy | 18 Jun 2026 | 12.00 USD |
| Jefferies | Farzin Haque | Buy | 1 Jul 2026 | 9.00 USD |
| Leerink Partners | Andrew Berens | Buy | 27 Apr 2026 | 10.00 USD |
| Lucid Cap Mkts | Unnamed analyst | Buy | 2 Mar 2026 | — |
| Lucid Capital Markets | Unnamed analyst | Buy | 2 Mar 2026 | 14.00 USD |
| Mizuho | Uy Ear | Buy | 20 Mar 2026 | 19.00 USD |
| Piper Sandler | Kelsey Goodwin | Buy | 6 Aug 2026 | 12.00 USD |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 27 Jan 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:52 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.